Anti-cancer properties of Escherichia coli Nissle 1917 against HT-29 colon cancer cells through regulation of Bax/Bcl-xL and AKT/PTEN signaling pathways

OBJECTIVE(S): Chemotherapies used to treat colon cancer might often fail due to the emergence of chemoresistance and side effects. Escherichia coli Nissle 1917 (EcN) is a beneficial probiotic, whose molecular mechanisms in the prevention of colon cancer are yet to be fully understood. The present st...

Descripción completa

Detalles Bibliográficos
Autores principales: Alizadeh, Siamak, Esmaeili, Abolghasem, Omidi, Yadollah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mashhad University of Medical Sciences 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7395184/
https://www.ncbi.nlm.nih.gov/pubmed/32774810
http://dx.doi.org/10.22038/ijbms.2020.43016.10115

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7395184/
https://www.ncbi.nlm.nih.gov/pubmed/32774810
http://dx.doi.org/10.22038/ijbms.2020.43016.10115

Ejemplares similares